Alfresa Holdings (TSE:2784) Research & Development: 円0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2784 Alfresa Holdings Corp TSE:2784
83 GF Score
Price 円2,414.00
GF Value 円2,542.44
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Alfresa Holdings Research & Development?

Alfresa Holdings TSE:2784 +0.21% 83 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:2784 with a GF Score™ of 83/100 and a GF Value™ of 円2,542.44 (Fairly Valued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Alfresa Holdings's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Alfresa Holdings  (TSE:2784) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alfresa Holdings Research & Development Related Terms

Alfresa Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Alfresa Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alfresa Holdings Research & Development Chart

Alfresa Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alfresa Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:2784
83GF Score
Alfresa Holdings Corp TSE:2784
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alfresa Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Alfresa Holdings (TSE:2784) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Alfresa Holdings and its competitors.
Is Alfresa Holdings' Research & Development too high?
Alfresa Holdings' current Research & Development is 円0 Mil. Overall, Alfresa Holdings has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Research & Development compare to MCK and COR?
Alfresa Holdings' Research & Development of 円0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Alfresa Holdings and its competitors. Alfresa Holdings's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (TSE:2784) is currently considered Fairly Valued. The stock's GF Value™ is 円2,542.44, compared to a current price of 円2,414.00 — trading 5.1% below its estimated fair value. The current Research & Development is 円0 Mil. Alfresa Holdings' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Alfresa Holdings (TSE:2784), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alfresa Holdings (TSE:2784) Overvalued in 2026?

Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued. The current stock price of 円2,414.00 is trading 5.1% below its estimated GF Value™ of 円2,542.44. GuruFocus considers Alfresa Holdings to be Fairly Valued.

Key valuation signals for TSE:2784:

  • Research & Development: 円0 Mil
  • GF Value™: 円2,542.44 vs. price of 円2,414.00 (5.1% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the TSE:2784 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alfresa Holdings Business Description

Other Exchanges ALFRY:USA
Address 1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
83GF Score

Get the complete analysis for TSE:2784

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,414.00
Price
円2,542.44
GF Value